BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sim W, Lim WM, Hii LW, Leong CO, Mai CW. Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases. World J Gastroenterol 2022; 28(18): 1934-1945 [PMID: 35664961 DOI: 10.3748/wjg.v28.i18.1934]
URL: https://www.wjgnet.com/2307-8960/full/v28/i18/1934.htm
Number Citing Articles
1
Songyu Guo, Zhenxia Wang. Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategiesFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1349308
2
Chin-King Looi, Lian-Chee Foong, Felicia Fei-Lei Chung, Alan Soo-Beng Khoo, Ee-Mun Loo, Chee-Onn Leong, Chun-Wai Mai. Targeting the crosstalk of epigenetic modifications and immune evasion in nasopharyngeal cancerCell Biology and Toxicology 2023; 39(6): 2501 doi: 10.1007/s10565-023-09830-9
3
Zheng Wu, Ze-Xuan Fang, Yan-Yu Hou, Bing-Xuan Wu, Yu Deng, Hua-Tao Wu, Jing Liu. Review of ferroptosis in colorectal cancer: Friends or foes?World Journal of Gastroenterology 2023; 29(3): 469-486 doi: 10.3748/wjg.v29.i3.469
4
Yuen-Fen Tan, Ling-Wei Hii, Wei-Meng Lim, Soon-Keng Cheong, Chee-Onn Leong, Maxine Swee-Li Yee, Chun-Wai Mai. Polyethylene glycol-phospholipid functionalized single-walled carbon nanotubes for enhanced siRNA systemic deliveryScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-80646-1
5
Yuxia Wu, Xiangyan Jiang, Zeyuan Yu, Zongrui Xing, Yong Ma, Huiguo Qing. Mechanisms of Anti-PD Therapy Resistance in Digestive System NeoplasmsRecent Patents on Anti-Cancer Drug Discovery 2025; 20(1): 1 doi: 10.2174/0115748928269276231120103256
6
Jian Hong, Saber Y. Adam, Shiqi Wang, Hao Huang, In Ho Kim, Abdelkareem A. Ahmed, Hao-Yu Liu, Demin Cai. Melatonin Modulates ZAP70 and CD40 Transcripts via Histone Modifications in Canine Ileum Epithelial CellsVeterinary Sciences 2025; 12(2): 87 doi: 10.3390/vetsci12020087
7
Sophia Ogechi Ekeuku, Effiong Paul Etim, Kok-Lun Pang, Kok-Yong Chin, Chun-Wai Mai. Vitamin E in the management of pancreatic cancer: A scoping reviewWorld Journal of Gastrointestinal Oncology 2023; 15(6): 943-958 doi: 10.4251/wjgo.v15.i6.943
8
Lei Jin, Daohai Qian, Xiaolei Tang, Yong Huang, Junwei Zou, Zhaoying Wu. SMYD2 Imparts Gemcitabine Resistance to Pancreatic Adenocarcinoma Cells by Upregulating EVI2AMolecular Biotechnology 2024; 66(10): 2920 doi: 10.1007/s12033-023-00908-7
9
Chin-King Looi, Li-Lian Gan, Wynne Sim, Ling-Wei Hii, Felicia Fei-Lei Chung, Chee-Onn Leong, Wei-Meng Lim, Chun-Wai Mai. Histone Deacetylase Inhibitors Restore Cancer Cell Sensitivity towards T Lymphocytes Mediated Cytotoxicity in Pancreatic CancerCancers 2022; 14(15): 3709 doi: 10.3390/cancers14153709
10
Yijia Tang, Guangzu Cui, Haicong Liu, Ying Han, Changjing Cai, Ziyang Feng, Hong Shen, Shan Zeng. Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cellsCancer Communications 2024; 44(6): 601 doi: 10.1002/cac2.12546
11
Mihaela Andreescu. Epigenetic Alterations That Are the Backbone of Immune Evasion in T-cell MalignanciesCureus 2024;  doi: 10.7759/cureus.51662
12
Jie Xu, Yaomei Tian, Die Hu, Xi Yan, Li Yang. Enhancing cancer immunotherapy and antiangiogenic therapy by regulating gut microbes: Opportunities and challengesMedComm – Oncology 2024; 3(3) doi: 10.1002/mog2.85
13
Zeynep Akpınar, Nilgün Gürbüz. Carvacrol is a Novel Natural Therapeutic Approach Through the Inhibition of Proliferation, Autophagy and Migration in Pancreatic Ductal Adenocarcinoma CellsSDÜ Tıp Fakültesi Dergisi 2024;  doi: 10.17343/sdutfd.1560561
14
Renzo Vera, María Julia Lamberti, Alina L. Gonzalez, Martín E. Fernandez-Zapico. Epigenetic regulation of the tumor microenvironment: A leading force driving pancreatic cancerPancreatology 2024; 24(6): 878 doi: 10.1016/j.pan.2024.07.005
15
Peizan Ni, Lilin Li, KunPeng Du, Pengkhun Nov, Duanyu Wang, Changqian Wang, Qianzi Kou, Ying Li, Yangfeng Zhang, Chongyang Zheng, Wen Fu, Jiqiang Li. Unveiling the immunological terrain of pancreatic ductal adenocarcinoma: strategies to prompt immunotherapy from Mendelian randomizationDiscover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02250-7